Picture of Theralase Technologies logo

TLT Theralase Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for Theralase Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.36-7.41-5.6-4.41-5.24
Depreciation
Amortisation
Non-Cash Items0.1870.4220.930.3420.241
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.730.17-0.05-0.238-0.452
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities-1.22-6.57-4.45-4.03-5.13
Capital Expenditures-0.134-0.533-0.165-0.101-0.07
Purchase of Fixed Assets
Other Investing Cash Flow Items0
Sale of Fixed Assets
Cash from Investing Activities-0.134-0.533-0.165-0.101-0.07
Financing Cash Flow Items-1.60
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.1318.6-0.058-0.0573.02
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.7811.5-4.67-4.19-2.18